» Articles » PMID: 24721123

Dietary Trimethylamine N-oxide Exacerbates Impaired Glucose Tolerance in Mice Fed a High Fat Diet

Overview
Journal J Biosci Bioeng
Date 2014 Apr 12
PMID 24721123
Citations 160
Authors
Affiliations
Soon will be listed here.
Abstract

Trimethylamine N-oxide (TMAO) is an oxidation product of trimethylamine (TMA) and is present in many aquatic foods. Here, we investigated the effects of TMAO on glucose tolerance in high fat diet (HFD)-fed mice. Male C57BL/6 mice were randomly assigned to the control, high fat (HF), and TMAO groups. The HF group was fed a diet containing 25% fat, and the TMAO group was fed the HFD plus 0.2% TMAO for 4 weeks. After 3 weeks of feeding, oral glucose tolerance tests were performed. Dietary TMAO increased fasting insulin levels and homeostasis model assessment-estimated insulin resistance (HOMA-IR) and exacerbated the impaired glucose tolerance in HFD-fed mice. These effects were associated with the expression of genes related to the insulin signal pathway, glycogen synthesis, gluconeogenesis and glucose transport in liver. mRNA levels of the pro-inflammatory cytokine MCP-1 increased significantly and of the anti-inflammatory cytokine IL-10 greatly decreased in adipose tissue. Our results suggest that dietary TMAO exacerbates impaired glucose tolerance, obstructs the hepatic insulin signaling pathway, and causes adipose tissue inflammation in mice fed a high fat diet.

Citing Articles

Associations of Plasma Gut Microbiota-Derived TMAO and Precursors in Early Pregnancy with Gestational Diabetes Mellitus Risk: A Nested Case-Control Study.

Wu Y, Bai H, Lu Y, Peng R, Qian M, Yang X Nutrients. 2025; 17(5).

PMID: 40077680 PMC: 11901518. DOI: 10.3390/nu17050810.


Therapeutic Strategies to Modulate Gut Microbial Health: Approaches for Chronic Metabolic Disorder Management.

Rondanelli M, Borromeo S, Cavioni A, Gasparri C, Gattone I, Genovese E Metabolites. 2025; 15(2).

PMID: 39997751 PMC: 11857149. DOI: 10.3390/metabo15020127.


The Gut Microbiota-Related Antihyperglycemic Effect of Metformin.

Szymczak-Pajor I, Drzewoski J, Kozlowska M, Krekora J, Sliwinska A Pharmaceuticals (Basel). 2025; 18(1).

PMID: 39861118 PMC: 11768994. DOI: 10.3390/ph18010055.


Gut microbiota derived metabolite trimethylamine N-oxide influences prostate cancer progression via the p38/HMOX1 pathway.

Zhou Y, Lv J, Jin S, Fu C, Liu B, Shen Y Front Pharmacol. 2025; 15():1526051.

PMID: 39850572 PMC: 11754881. DOI: 10.3389/fphar.2024.1526051.


The role of intestinal flora in metabolic dysfunction-associated steatotic liver disease and treatment strategies.

Wang L, Sun J, Chen S, Sun Y, Zheng Y, Feng J Front Med (Lausanne). 2025; 11():1490929.

PMID: 39839647 PMC: 11746088. DOI: 10.3389/fmed.2024.1490929.